Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Acceptance of Stryphnodendron Adstringens Intimate Soap
NCT06085898Not yet recruiting
- Sponsor
- Biolab Farmacêutica
- Start
- Nov 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Single-blind, single-arm trial of Stryphnodendron adstringens in bacterial vaginosis (BV), sponsored by Biolab Farmacêutica. Primary endpoint: Dermatological and gynecological evaluation criteria. Planned start Nov 2023; status: not yet recruiting.
02
Drugs
Stryphnodendron adstringens
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT06085898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06085898.